최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.47 no.6, 2003년, pp.345 - 351
Heptaplatin, cis-Malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II), is a novel platinum-based antitumor agent with clinical potential against human stomach cancer and the 3rd generation of the cisplatin. This study was performed to study how cisplain, heptaplatin and sunpl...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Kaufmann, S. H. : Induction of endonucleolytic DNA cleavagein human acute myelogenous leukemia cells by etoposide, camptoyhecin, and other cytotoxic anticancer drugs : acautionary note. Cancer Res. 49, 5870 (1989)
Barry, M. A., Behnke, C. A. and Eastman, A. : Activation of programmed cell death (apoptosis) by cisplatin, other anti-cancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40, 2353 (1990)
O'Connor, P. M., Wastermann, K., Sarang, M., Magrath, I., Bohr, V. A. and Kohn,K W. : Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res. 51, 6550 (1991)
Miyashita, T. and Reed, J. C. : Blood 81, 151 (1993)
Kim, D.-K., Kim, C., Gam,J., Cho, Y.-B., Hong, w.-S. and Park, J.-G. : J Medicinal Chemistry 37, 1471 (1994)
Loehrer, P. J. and Einhorn, L. H. : Drugs five years later. cisplatin. Ann. Inter. Med. 100, 704 (1984)
Ozols, R. E. and Young, R. C. : Chemotherapy of ovarian cancer. Semin. Oncol. 11, 251 (1984)
Fiorentino, M. V. and Ghiotto, C. : Platinum, the synergistic drug, from clinical evidence to laboratory suggestions. in platinum and other metal coordination compounds in cancer chemotherapy;Nicolini, M., Ed., Martinus Nijhoff Publishing. Boston 415 (1988)
Choksi, A. and Hong, W. K : Chemotherapy of head and neck cnacer. Boston 375 (1988)
Paccagnella, A., Favaretto, G. and Fiorentino, M. V. : Chem-otherapy of lung cnacer. Boston 394 (1988)
Wagener, D. J., Yap, S. H., Wobbes, T., Burghouts, J. T., van Dam, F E., Hillem, H. E, Hoogendooorn, G. J., Scheerder, H. and van der Vert, S. G. : Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer.Cancer Chemother. Pharmacol. 15, 86 (1985)
Prestayko, A. w., Crooke, S. T. and Carter, S. K, Eds. : Academic Press. Ins.New York, 317 (1980)
Von Hoff, D. D., Schilsky, R, Reichert, C. M., Reddick, R. L., Rozencweig, M., Young, R C. and Muggia, F. M. : Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treat. Rep. 63, 1527 (1979)
Krakoff, I. H. : Nephrotoxicity of cis-dichlorodiammine-platinum (II). Cancer Treat. Rep. 63, 1523 (1979)
Iahibiki, K, Kumai, K., Kodaira, S., Abe, O., Yamamoto, K., Oodchi, T., Fukaya,Y., Kimura, K., Takamatsu, K., Ootsuka, E., Sakabe, T., Nishiyama, K., Sekizawa, Y., Ooide, N., Tsuchiya, S., Togo, S., Ishida, T., Mishima, Y., Ogoshi, K and Mitomi., T. : Phase II study with cisplatin in dvanced stomach and colon carcinoma. Jpn. J Cancer Chemother. 16, 3185 (1989).
Hong, W. S., Saijo, N., Sasaki, Y., Minato, K., Nakano, H., Nakagawa, K., Fujiwara, Y., Nomura, K. and Twentyman, P. R. : Establishment and characterization of cisplatin-resistant sub-lines of human lung cancer lines. Int. J. Cancer 41, 462 (1988)
Inoue, K., Mukaiyama, T., Mitsui, I. and Ogawa, M. : In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. Cancer Chemother. Pharmacol. 15, 208 (1985)
Ozols, R. E : Pharmacologic rebersal of drug resistance in ovarian cancer. Semin. Oncol. 12, 7 (1985)
Kim, D. K., Kim, H. T., Cho, Y. B., Tai, T. H., Ahn, J. S., Kim, T. S., Kim, K. H. and Hong, W. S. : Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminome-thyl)-2-isopropy1-1,3-dioxolane]platinum (II), a new platinum analogue, as an anticancer agent. Cancer Chemother Pharmacl. 35, 441 (1995).
Glotzer, M. : Cyclin is degraded by the ubiquitin pathway. Nature 349, 132 (1991)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.